# Treatment of Central Sleep Apnoea in Patients With Heart Failure With Nasal High Flow Therapy (nHFT)

> **NCT03085641** · NA · TERMINATED · sponsor: **University Medical Center Groningen** · enrollment: 6 (actual)

## Conditions studied

- Central Sleep Apnea
- Cheyne-Stokes Respiration

## Interventions

- **DEVICE:** Nasal high flow oxygen therapy

## Key facts

- **NCT ID:** NCT03085641
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-15
- **Primary completion:** 2018-10-18
- **Final completion:** 2018-10-18
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Side effects
- **Last updated:** 2018-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03085641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03085641, "Treatment of Central Sleep Apnoea in Patients With Heart Failure With Nasal High Flow Therapy (nHFT)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03085641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*